Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-106144
Filing Date
2024-09-12
Accepted
2024-09-12 21:00:51
Documents
1
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 7417
  Complete submission text file 0000950170-24-106144.txt   9653
Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Issuer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 485 STATE HWY 1 SOUTH SUITE B 305 ISELIN NJ 08830
Business Address 485 STATE HWY 1 SOUTH SUITE B 305 ISELIN NJ 08830 732-636-2950
Biocon Pharma Inc. (Reporting) CIK: 0002036121 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42271 | Film No.: 241296249

Mailing Address 20TH KM, HOSUR ROAD ELECTRONIC CITY, BENGALURU KARNATAKA K7 560100
Business Address 20TH KM, HOSUR ROAD ELECTRONIC CITY, BENGALURU KARNATAKA K7 560100 91 80 2808 2808
Biocon Ltd (Reporting) CIK: 0002036170 (see all company filings)

State of Incorp.: K7 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42271 | Film No.: 241296250